Piosteris M 500 Pioglitazone and Metformin Piosteris M 500 are two different medications commonly used to treat type 2 diabetes. When they are combined in a single medication with sustained-release properties, it is usually referred to as “Piosteris M 500.“ Pioglitazone is an oral medication that belongs to a class of drugs known as thiazolidinediones. It helps improve insulin sensitivity in the body's cells and reduces the amount of glucose produced by the liver. Pioglitazone is typically used as an adjunct to diet and exercise to manage blood sugar levels in people with type 2 diabetes. Metformin is also an oral medication, and it is classified as a biguanide. It primarily works by reducing the production of glucose by the liver and improving the body's sensitivity to insulin, allowing better glucose uptake by cells. Metformin is often considered a first-line treatment for type 2 diabetes. When Piosteris M 500 are combined into a single medication with sustained-release properties, it means that the medication is formulated to release the active ingredients slowly over time. This can help maintain more stable blood sugar levels throughout the day and reduce the risk of side effects, such as gastrointestinal upset, which can sometimes be associated with immediate-release forms of Metformin. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order NOW https://www.sterisonline.com/product/piosteris-m-500-134243